This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Les Laboratoires Servier. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Randi Westh Hansen: Innovating in Cancer Treatment
Introduction
Randi Westh Hansen is a prominent inventor based in Roskilde, Denmark, known for his significant contributions to the field of immunology and cancer treatment. With a notable portfolio of four patents, Hansen has been instrumental in developing innovative therapies aimed at enhancing immunity and combating cancer through targeted antibodies.
Latest Patents
Among Hansen's latest innovations are groundbreaking patents related to anti-FLT3 antibodies and anti-NKG2A antibodies. The patent for anti-FLT3 antibodies revolves around methods of using these antibodies to enhance immunity in patients and treat cancer effectively. Similarly, the invention of anti-NKG2A antibodies focuses on utilizing these specific antibodies to bolster the immune response in patients suffering from cancer, showcasing Hansen's commitment to advancing therapeutic options in oncology.
Career Highlights
Currently affiliated with Les Laboratoires Servier, a leading pharmaceutical company, Randi Westh Hansen has made notable strides in his career through his pioneering research and development efforts in antibody therapies. His patents reflect a deep understanding of immunology and a dedicated pursuit of innovative treatments that can make a meaningful impact in the medical field.
Collaborations
Throughout his career, Hansen has collaborated with talented professionals such as Trine Lindsted and Maria Carlsen Melander. These partnerships have enriched his research endeavors and contributed to the successful development of his patented inventions, fostering a collaborative environment that encourages innovation.
Conclusion
Randi Westh Hansen stands out as an influential inventor who has made significant advancements in cancer immunotherapy. His latest patents not only hold promise for improving patient outcomes but also demonstrate the vital role of innovation in medicine. Through his work at Les Laboratoires Servier and collaborations with esteemed colleagues, Hansen continues to push the boundaries of what is possible in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile